Kura Oncology

KURANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$849.571 M

$9.57 +3.13%

Close of 7 Aug 2026

Revenue

$67.5M

#2647 by revenue

Earnings

-$278.7M

Loss-making

Shares outstanding

88,329,759

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#172Design TherapeuticsDSGN$875.5M
#173Theravance BiopharmaTBPH$872.8M
#174Kura OncologyKURA$849.6M
#175Aclaris TherapeuticsACRS$825.4M
#176Climb BioCLYM$801.7M

Where these numbers come from

Share counts and financials for Kura Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.